CCEL
CCEL
AMEX · Health Care

Cryo-Cell Intl Inc

$5.40
+0.26 (+5.06%)
Financial Highlights (FY 2026)
Revenue
31.54M
Net Income
-2,427,663
Gross Margin
76.6%
Profit Margin
-7.7%
Rev Growth
+1.3%
D/E Ratio
0.45
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 76.6% 76.6% 58.0% 58.0%
Operating Margin 1.5% 1.4% 14.0% 13.9%
Profit Margin -7.7% -7.3% 13.7% 12.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 31.54M 31.13M 7.57M 7.87M
Gross Profit 24.17M 23.85M 4.39M 4.56M
Operating Income 482.6K 428.6K 1.06M 1.09M
Net Income -2,427,663 -2,156,218 1.04M 986.8K
Gross Margin 76.6% 76.6% 58.0% 58.0%
Operating Margin 1.5% 1.4% 14.0% 13.9%
Profit Margin -7.7% -7.3% 13.7% 12.6%
Rev Growth +1.3% +1.3% +20.2% +12.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 6.15M 6.15M 9.02M 8.61M
Total Equity 13.56M 13.56M 15.90M 15.89M
D/E Ratio 0.45 0.45 0.57 0.54
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 1.23M 1.16M 1.71M 1.80M
Free Cash Flow — — 1.30M 1.03M